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The chronic effects of cocaine abuse on brain structure and function are blamed for the inability of most addicts to remain
abstinent. Part of the difficulty in preventing relapse is the persisting memory of the intense euphoria or cocaine ‘‘rush’’. Most
abused drugs and alcohol induce neuroplastic changes in brain pathways subserving emotion and cognition. Such changes
may account for the consolidation and structural reconfiguration of synaptic connections with exposure to cocaine. Adaptive
hippocampal plasticity could be related to specific patterns of gene expression with chronic cocaine abuse. Here, we compare
gene expression profiles in the human hippocampus from cocaine addicts and age-matched drug-free control subjects.
Cocaine abusers had 151 gene transcripts upregulated, while 91 gene transcripts were downregulated. Topping the list of
cocaine-regulated transcripts was RECK in the human hippocampus (FC=2.0; p,0.05). RECK is a membrane-anchored MMP
inhibitor that is implicated in the coordinated regulation of extracellular matrix integrity and angiogenesis. In keeping with
elevated RECK expression, active MMP9 protein levels were decreased in the hippocampus from cocaine abusers. Pathway
analysis identified other genes regulated by cocaine that code for proteins involved in the remodeling of the cytomatrix and
synaptic connections and the inhibition of blood vessel proliferation (PCDH8, LAMB1, ITGB6, CTGF and EphB4). The observed
microarray phenotype in the human hippocampus identified RECK and other region-specific genes that may promote long-
lasting structural changes with repeated cocaine abuse. Extracellular matrix remodeling in the hippocampus may be
a persisting effect of chronic abuse that contributes to the compulsive and relapsing nature of cocaine addiction.
Citation: Mash DC, Ffrench-Mullen J, Adi N, Qin Y, Buck A, et al (2007) Gene Expression in Human Hippocampus from Cocaine Abusers Identifies
Genes which Regulate Extracellular Matrix Remodeling. PLoS ONE 2(11): e1187. doi:10.1371/journal.pone.0001187
INTRODUCTION
A major goal in drug abuse research is to identify key molecular
mechanisms that underlie the development of compulsive drug
use. The persisting cravings for cocaine that remain after
a protracted period of withdrawal may be due to long-lasting
structural changes in certain brain regions. Recent observations
suggest that hippocampal learning and memory of the drug
euphoria may drive the maladaptive behaviors that increase the
risk of relapse to cocaine use [1–3]. The hippocampus is involved
in short and long-term memory processing [4] and one important
target of hippocampal projections is the nucleus accumbens
(NAC), a region involved in drug reward circuitry [for review, 5].
Synchronous activity in the hippocampus and nucleus accumbens
may be a motivation-to-action interface [6]. Recent behavioral
data demonstrate that hippocampal theta stimulation is sufficient
to drive reinstatement of cocaine intake in rats extinguished from
self-administration [7]. Long-term potentiation (LTP) in the rat
hippocampus is modulated by cocaine exposure, suggesting further
that drug-induced changes in the hippocampal formation may
have some role in the addictive state [8].
By using high density genome-wide arrays, we profiled
hippocampal gene expression in cocaine abusers to identify new
targets that may play a role in cocaine dependence. Target
validation and protein measures were done for selected genes to
further confirm functional relevance. This transcriptome survey in
the human hippocampus identified an unexpected elevation in
RECK (reversion-inducing-cysteine-rich protein with kazal mo-
tifs), an endogenous inhibitor of matrix metalloproteinases
(MMPs). MMPs remodel the pericellular environment, primarily
through cleavage of extracellular matrix (ECM) proteins and
receptors [9–11]. Brain ECM proteins form the scaffolding for
neurons and glia to cling to and make up approximately 20% of
the brain. The balance in endogenous tissue inhibitors of MMP
activity sustain or break down existing cell adhesion molecules,
permitting the reconfiguration of synaptic connections. Gene
expression identified hippocampal transcripts involved in angio-
genesis, cell adhesion, synaptic formation and cell communication
that were regulated by cocaine exposure. Regional gene expression
results shown here provide evidence for active transcripts that
function to remodel the hippocampal extracellular matrix in
human cocaine addiction.
RESULTS
Brain tissues were taken from autopsy cases according to criteria
described by the National Association of Medical Examiners
(NAME) Committee on Cocaine-related Deaths for documenting,
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[12,13]. The investigation of any drug-related death requires
knowledge of the circumstances of death, the death scene, and past
medical history. It is also necessary to have the results of the forensic
toxicologic analysis and those of a forensic autopsy examination
prior to classifying that a cause and manner of death is associated
with acute cocaine exposure or chronic cocaine use that leads
ultimately to a fatal pathologic process. The cocaine users had long-
standing histories of cocaine abuse and all subjects had informant
reports of ‘‘binge’’ cocaine use in the days immediately before death.
All of the cocaine deaths were due to cocaine intoxication. Cocaine
and its main metabolite benzoylecgonine (BE) were measured in
blood and urine at the time of death for all cases (Table 1). Control
subjects were age-matched and drug-free. The manner of death for
the control subjects was classified as a natural or accidental death.
Three of the control cases were homicide victims of gun shot
wounds, one was a blunt trauma death, and the remaining seven
cases died from sudden cardiac death. Sudden cardiac death is an
event that is non-traumatic, non-violent, unexpected, and resulting
from sudden cardiac arrest within six hours of previously witnessed
normal health [14]. Review of the cause and manner of death
demonstrated that all of the cocaine abusers and control subjects
died suddenly without evidence of any significant agonal conditions.
Persons that suffered prolonged agonal states, such as with
respiratory arrest, multi-organ failure or coma, have lower pH in
the brain, while those who experienced brief deaths, associated with
accidents or cardiac events have normal pH values [15].
Regulation of Gene Expression by Cocaine
Correlational analysis of postmortem interval (PMI) and RNA
quality control parameters showed no significant effect for the two
sample groups in the human hippocampus for the initial cohort of
cocaine cases (n=10) and control subjects (n=11) (Pearson
correlation, R
2=0.045). Analysis of the demographic parameters
demonstrated no significant differences in terms of age, PMI or pH
between the control subjects and cocaine abusers (Table 1).
Individual data for the QC metrics for the total number of cases
and controls are shown as supplementary materials (Table S1).
Careful Affymetrix QC analysis and matching of the microarrays
gave a final cohort of age-matched controls (n=8) and cocaine
abusers (n=8). Table 2 summarizes the QC metrics for this final
cohort of controls and cocaine abusers. We observed no significant
correlation between quality control parameters such as noise
(RawQ), number of genes detected as present across arrays, scale
factor, b-actin and GAPDH 59/39 ratios and pH or PMI in several
regions tested. These data suggest that RNA quality was accept-
able, probably reflecting our brain recruitment procedures, which
are limited to sudden death without medical intervention,
prolonged agonal periods or extended PMI.
Using hierarchical clustering, we compared the gene expression
profile of this final set of cocaine abusers to that of the normal
controls. A Volcano plot illustrates the variance in gene numbers
at different p-values (Fig. 1a). Gene expression changes in
postmortem brain are usually modest (less than twofold) in studies
of psychiatric disorders [16]. A total of 242 differentially expressed
genes in the hippocampus of cocaine abusers were observed using
combined criteria (61.3 fold-change and p#0.05). Of these 242
differentially expressed genes, 151 genes were upregulated and 91
genes were downregulated in cocaine abusers as compared to the
age-matched and drug-free control subjects.
Additional confirmation of these selected genes was obtained
with hierarchical clustering and shown as a Clustered Image Map
(CIM) for expression of the 242 genes between control subjects
and cocaine abusers (Fig. 1b). The CIM clearly illustrates the
separationofthecocaineabusersfromcontrolsubjectswithadefined
cluster order for the individual subjects. Additionally, two distinct
gene cluster patterns for the cocaine abusers were observed: a large
upregulation and a smaller downregulation pattern of expression.
However, the individual genes of interest each showed very clearly
defined clusters with primarily unknown genes (EST’s and
hypothetical proteins). With RECK and protocadherin 8 (PCDH8),
the genes were up-regulated by cocaine exposure (Fig. 1b). The
genes coding for connective tissue growth factor (CTGF) and EPH
receptor B4 (EphB4), were downregulated in this cluster. Results of
the principal components analysis (PCA) of the initial 15,336 gene-
set resulting from ‘‘Present Calls’’ (MAS 5.0) on the HG-U133 A
chip from control subjects and cocaine abusers, demonstrated that
the first three components accounted for 35.2% of the total variance
(data not shown). PCA analysis based on the initial gene set did not
discriminate cocaine abusers from controls. However, PCA analysis
based on the selected 242 differentially regulated genes did
discriminate groups (Fig. 1c). The first three components accounted
for 52.9% of the total variance with components 1, 2 and 3
accounting for 36.3, 9.5 and 7.1% of the variance, respectively.
Table 1. Demographics, postmortem interval (PMI), brain pH and toxicology
..................................................................................................................................................
Group N Age Ethnicity Gender PMI pH Cocaine BE CE
CTRL 11 31.963.5 7C, 4B 10M, 1F 14.461.9 6.5360.04 n.d. n.d. n.d.
COC 10 34.061.9 7C, 3B 9M, 1F 13.161.1 6.5060.07 6.5162.69 5.4161.21 0.4460.12 (5 out of 10)
Abbreviations: BE: benzoylecgonine; CE, cocaethylene; COC, cocaine abuser; CTRL, drug-free control.
doi:10.1371/journal.pone.0001187.t001
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Table 2. Quality control parameters for brain sample
microarrays from hippocampus.
......................................................................
RawQ
Scale
Factor
Present
Calls
Actin 59/39
ratio
GAPDH 59/39
ratio
U133A, Mean6SEM
CTRL 2.7760.17 0.9560.12 96466215 0.5160.04 0.8560.03
COC 2.7160.11 0.9360.11 100816359 0.4260.05 0.8460.07
U133B, Mean6SEM
CTRL 2.4360.14 2.3360.17 66296203 0.5160.04 0.7260.05
COC 2.8660.18 2.2460.19 65736140 0.4360.05 0.6760.06
Abbreviations: COC, cocaine abuser; CTRL, drug-free control; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase
*The lower percent present calls in the B chip compared to the A chip is due to
the fact that the B chip contains primary probe sets representing EST clusters.
As a result overall signal intensities on the B chip are lower which is reflected
by higher scaling factors. Note that RNA-QC metrics (including b-actin and
GAPDH signal ratios) are consistent across chips. Values were derived from
Microarray Analysis Suite version 5.0 analysis (available at http://
www.affymetrix.com).
doi:10.1371/journal.pone.0001187.t002
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Cocaine Regulated Transcripts
PLoS ONE | www.plosone.org 2 November 2007 | Issue 11 | e1187Biopathway and cluster analysis
Gene Ontology (GO) analysis using GoSurfer revealed major
categories for genes significantly altered by cocaine, which
demonstrated changes in gene expression related to specific
molecular functions, including angiogenesis, apoptosis and cell
death, cell adhesion, neurogenesis and axon guidance. Our brain
gene expression was used only as a first step to screen for potential
targets dysregulated by cocaine in the human hippocampus in
order to identify molecular mechanisms that may be relevant to
cocaine dependence. Of particular interest was the observation of
a number of different molecular functions associated with
remodeling of the cytomatrix. Within the cell adhesion pathway,
there were 15 genes differentially regulated by cocaine (Table 3).
Topping the list of upregulated transcripts in this category of
molecular function was RECK. Other upregulated transcripts
associated with cell adhesion and matrix remodeling included
laminin beta 1 (LAMB1), integrin beta 6 (ITGB6), three members
of the protocadherin family (PCDH8, PCDHA2, PCDHGA1),
catenin, beta interacting protein 1 (CTNNBIP1), fibronectin like
domain containing leucine rich transmembrane protein 3
(FLRT3), connective tissue growth factor (CTGF) and cell
differentiation antigen CD44. There were three transcripts
upregulated by cocaine that are associated with neurogenesis
and axon guidance pathways, including oligophrenin 1 (OPHN1),
Figure 1. Gene expression in the human hippocampus for cocaine abusers and control subjects. A, Volcano plot illustrating the total number of
genes (13,662) meeting the criterion ($75% present call). For all genes detected on the Affymetrix Human Genome HGU133 A & B Chip Set, each
point represents a gene plotted as a function of fold-change (Log (fold change), y-axis) and statistical significance (-Log (p-value), x-axis). Vertical lines
represent p values of 0.05 and 0.01, respectively. The upper and lower horizontal lines represent fold changes of +1.3 and 21.3, respectively. Green
represents downregulation, while red illustrates upregulation in group comparisons. B, Clustered Image Map (left panel) of the relative change in
gene expression between the control and cocaine exposure groups. The color change reflects relative change according to the scale shown; red
indicates positive fold change and blue indicates negative fold change. B) Representative genes (left panel): RECK, OPHN1, CTGF, EPHB4 and PCDH8
(from left to right). C, Principal Components Analysis (PCA) reveals separation between groups for the 242 differentially expressed genes. Red
represents the cocaine abusers (COC, n=8) and blue illustrates the control subjects (CTRL, n=8).
doi:10.1371/journal.pone.0001187.g001
Cocaine Regulated Transcripts
PLoS ONE | www.plosone.org 3 November 2007 | Issue 11 | e1187Table 3. Summary and functional categorization of select genes displaying significant fold change (|FC|.1.3) in hippocampus of
cocaine abusers.
..................................................................................................................................................
Gene Symbol Accession No. Protein Name Fold-Change P-Value
1 P-Value
2
Angiogenesis
RECK NM_021111.1 Reversion-inducing-cysteine-rich protein with kazal motifs 2.02 0.034 0.0452
MAN1 NM_166651.1 Integral inner nuclear membrane protein 1.46 0.022 0.0415
CCM1 NM_001013406.1 Cerebral cavernous malformations 1 1.44 0.047 0.0471
RSN NM_002956.2 Restin 1.35 0.010 0.0398
EGFR NM_005228.3 Epidermal growth factor receptor 21.30 0.033 0.0427
CSRP2 NM_001321.1 Cysteine and glycine-rich protein 2 21.36 0.017 0.0402
EPHB4 NM_004444.4 Ephrin type-B receptor 4 21.47 0.005 0.0380
CTGF NM_001901.2 Connective Tissue Growth Factor 21.52 0.017 0.0402
Apoptosis & Cell Death
PPID NM_001004279.1 Peptidylprolyl isomerase D (cyclophilin D) 1.73 0.035 0.0443
PDCD7 NM_005707.1 Programmed cell death 7 1.38 0.033 0.0415
REQ NM_006268.3 Requiem, apoptosis response zinc finger gene 1.37 0.002 0.0390
PDCD8 NW_004208.2 Programmed cell death 8 1.35 0.018 0.0402
INHA NM_002191.2 Inhibin, alpha 21.32 0.014 0.0402
ABS NM_016222.2 Dead-box protein abstrakt 21.42 0.033 0.0426
Cell Adhesion
RECK NM_021111.1 Reversion-inducing-cysteine-rich protein with kazal motifs 2.02 0.034 0.0452
LAMB1 NM_002291.1 Laminin, beta 1 1.67 0.011 0.0427
SGCB NM_000232.3 Beta sarcoglycan 1.50 0.013 0.0427
PCDHGA1 NM_018912.2 Protocadherin gamma subfamily alpha, 1 1.48 0.011 0.0398
MAN1 NM_166651.1 Integral inner nuclear membrane protein 1.46 0.022 0.0415
PCDH8 NM_002590.2 Protocadherin 8 1.45 0.043 0.0474
LIN7C NM_018362.2 Lin-7 homolog C (C. elegans) 1.44 0.032 0.0402
FLRT3 NM_013281.2 Fibronectin leucine rich transmembrane protein 3 1.40 0.024 0.0468
PCDHA2 NM_018905.2 Protocadherin alpha 2 1.36 0.024 0.0402
ITGB6 NM_000888.3 Integrin, beta 6 1.35 0.006 0.0398
RSN NM_002956.2 Restin 1.35 0.010 0.0398
CTNNBIP1 NM_001012329.1 Catenin, beta interacting protein 1 21.33 0.023 0.0415
CD44 NM_000610.3 CD44 antigen (homing function) 21.37 0.014 0.0402
CMAR NM_003119.2 Cell matrix adhesion regulator 21.49 0.049 0.0498
CTGF NM_001901.2 Connective Tissue Growth Factor 21.52 0.017 0.0402
Neurogenesis and Axon Guidance
PPFIBP1 NM_003622.2 Liprin beta 1 1.52 0.050 0.0481
OPHN1 NM_002547.1 Oligophrenin 1 1.47 0.027 0.0414
AXOT NM_022826.2 Axotrophin 1.34 0.011 0.0398
SHANK2 NM_012309.1 SH3 and multiple ankyrin repeat domains 2 21.37 0.005 0.0368
SEMA6A NM_020796.3 Semaphorin 6A 21.45 0.009 0.0398
Receptors & Signal Transduction
SGKL NM_001033578.1 Serum/glucocorticoid regulated kinase-like 1.91 0.024 0.0431
TIPRL NM_001031800.1 Putative MAPK activating protein 1.33 0.019 0.0427
SYT11 NM_152280.2 Synaptotagamin XI 1.33 0.040 0.0443
CCKBR NM_176875.2 Cholecystokinin B receptor 21.30 0.007 0.0398
EGFR NM_005228.3 Epidermal growth factor receptor 21.30 0.033 0.0427
PAK6 NM_020168.3 p21 CDKN1A -activated kinase 6 21.32 0.014 0.0402
DRD2 NM_000795.2 Dopamine Receptor D2 21.35 0.029 0.0402
SHANK2 NM_012309.1 SH3 and multiple ankyrin repeat domains 2 21.37 0.005 0.0368
EPHB4 NM_004444.4 Ephrin type-B receptor 4 21.47 0.005 0.0380
PTPRB NM_002837.3 Protein tyrosine phosphotase, recceptor type, B 21.47 0.005 0.0317
PIM1 NM_002648.2 Proto-oncogene serine/threonine-protein kinase 21.58 0.008 0.0402
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Cocaine Regulated Transcripts
PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1187axotropin (AXOT), and liprin beta 1 (PPFIBP1). The most
commonly overrepresented ontologies-genes based on the rankings
and P-values in the hippocampus from the GSR analysis in
ErmineJ. were similar to GoSurfer and included genes in the
molecular function category (7 classes) and one biological process
class (cell cycle). In this analysis, MCM3 and ATP8A2 were the
two most over-represented genes, closely followed by one of our
validated genes, EphB4.
A number of different receptors, ion channels and transporters
were regulated in the hippocampus by cocaine (Table 3). These
included the D2 dopamine (DRD2) and cholecystokinin receptor
(CCKBR). The hyperpolarization-activated cyclic nucleotide-
gated potassium channel 2 (HCN2) was upregulated 1.8-fold.
The KCNAB1 potassium channel gene was downregulated in
contrast to the marked upregulation of HCN2. There were six
regulators of apoptosis and cell death, four transcripts upregulated
and two downregulated by chronic cocaine exposure.
As the final control group selected from the PCA analysis
consisted of one female and seven male patients compared with
a cocaine cohort of eight males (242 dysregulated genes), we further
tested for a possible gender effect between the two groups. For this
comparison, the control group had the female control (age 24 yrs.)
and one age-matched male cocaine abuser (age 23 yrs.) removed to
give a final count of seven subjects per group. There were 250 genes
dysregulated by cocaine (163 and 87 up- and down regulated,
respectively) as compared to the 242 genes. However, the genes in
common for both datasets demonstrated further that there was no
apparent gender bias resulting from the inclusion of the one female
control subject on the genes of interest (data not shown). Thus, the
validation of selected transcripts was done using the same cohort of
eight subjects from the cocaine and control groups.
Target Validation
Of the total number of dysregulated genes in the human
hippocampus, RECK had the largest upregulated fold-change in
cocaine abusers (FC=2.0; p,0.05). RT-PCR was used to validate
the differential mRNA expression levels of RECK and three selected
genes that were identified by functional cluster analysis (PCDH8,
CTGF and EphB4; Fig. 1b). Differential expression of RECK was
confirmed on independent samples from the same cases (Figs. 2 and
3). Altered expression of three other transcripts PCDH8, CTGF and
EphB4 were confirmed by RT-PCR analysis (Fig. 3) in agreement
with the microarray results shown in Figure 2. Confirmation of
protein levels for three of the four genes selected was done based on
availability of commercial antibodies. Quantitation of immunopo-
sitive bands from Western blots demonstrated higher RECK and
PCDH8 and lower CTGF protein expression in cocaine abusers
compared to age-matched and drug-free control subjects (Fig. 4).
Additional experiments were performed on the cohort of cocaine
abusers (N=8) and control subjects (N=8) to further validate
selected gene transcripts incocaine-induced changes inhippocampal
function. The expanded qPCR results of ten genes (RECK, SGKL,
HCN2, LAMB1, OPHN1, PCDH8, EphB4, ITGB6, CTGF,
CTNNBIP1) normalized to 18S rRNA are shown in Table 4. The
Figure 2. Graphic representation of the observed changes in RECK,
PCDH8, CTGF, and EPHB4 gene expression. Raw Affymetrix data
(Microarray Analysis Suite version 5.0) illustrate the differential
expression of these genes in the hippocampus. Box plot illustrates
range and median values. **p#0.001; *p#0.01
doi:10.1371/journal.pone.0001187.g002
Gene Symbol Accession No. Protein Name Fold-Change P-Value
1 P-Value
2
Transcriptional & Translational Regulators
NFE2L1 NM_003204.1 Nuclear factor (erythroid-derived 2)-like 1 1.38 0.016 0.0402
RYBP NM_012234.4 RING1 and YY1 binding protein 1.37 0.027 0.0463
NFYB NM_006166.3 Nuclear transcription factor Y, beta 1.30 0.055 0.0498
MEF2D NM_005920.2 Myocyte enhancer factor 2D 21.38 0.032 0.0443
Ion Channels & Transport
HCN2 NM_001194.2 hyperpolarization activated cyclic nucleotide-gated potassium channel 2 1.78 0.037 0.0459
SLC35A3 NM_012243.1 Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter),
member 3
1.35 0.031 0.0426
CLIC1 NM_001288.4 Chloride intracellular channel 1 21.35 0.045 0.0464
SLC9A2 NM_003048.3 Solute carrier family 9 (sodium/hydrogen exchanger), isoform 2 21.35 0.015 0.0398
ORCTL4 NM_004803.2 Organic cationic transporter-like 4 21.45 0.028 0.0402
KCNAB1 NM_003471.2 Potassium voltage-gated channel, shaker-related subfamily beta member 21.46 0.014 0.0402
1P-values obtained from ANOVA t-test.
2P-values corrected for multiple testing by the Benjamini-Hochberg method.
doi:10.1371/journal.pone.0001187.t003
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..................................................................................................................................................
Cocaine Regulated Transcripts
PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1187fold change values determined by qPCR are ingood agreement with
the microarray data shown in Table 3 for these transcripts.
Downregulation of MMP9 protein in cocaine abusers
We examined whether the target molecules of RECK, MMP2 and
MMP9 were regulated by cocaine abuse. The microarray and RT-
PCR results demonstrated that neither transcript was regulated by
cocaine in the human hippocampus (data not shown). Previous
studies have demonstrated that increased expression of RECK
results in downregulation of MMPs at a post-transcriptional level
[17,18]. Since MMP2 and MMP9 are expressed in brain, we
conducted additional experiments using Western blot and gelatin
zymography to measure protein expression. MMP9 protein in the
hippocampus from cocaine users (N=8) and control subjects
(N=8) gave a single band at the expected molecular mass of
92 kDa (Fig. 5a). MMP9-positive bands were consistently less
dense in the cocaine users (p,0.01). A single band was observed
for MMP2 at the expected molecular mass of 72 kDa in cocaine
users and in control subjects (Fig. 5a). In contrast to MMP9, there
was no change in MMP2 and a-tubulin (50 kDa) levels between
groups. Densitometric analysis of MMP2 immunoblots gave values
for cocaine users that were not different from control subjects.
These results demonstrate that the cocaine-induced down-
regulation of MMP9 was not accompanied by changes in MMP2.
Representative zymography gels of active MMP2 and MMP9
are shown in Figure 5b. In the human hippocampus, gelatinolytic
activities at 72 and 92 kDa corresponded to the proenzyme forms
of MMP2 and MMP9, respectively. The zymograms showed
a reproducible reduction in MMP9, but no change in MMP2 in
cocaine abusers. In keeping with the immunoblot evidence of
a decrease in total protein, gelatin zymography demonstrates that
cocaine exposure downregulates active MMP9 in human hippo-
Figure 4. Western blot analysis of RECK, CTGF, and EphB4 protein
expression in human postmortem hippocampus. A, Representative
immunoblots with antibodies against human RECK, CTGF, and EPHB4
demonstrate elevated RECK and decreased CTGF, EPHB4 immunopo-
sitive bands in the human hippocampus from cocaine overdose
subjects as compared with age-matched, drug-free control subjects
(n=8, respectively). B, Quantitation of protein expression. Optical
density measurements are shown as percent control (y-axis). Data are
means6SEM. **p=0.01 (one-tailed t-test), *p=0.05 (one-tailed t-test).
doi:10.1371/journal.pone.0001187.g004
Figure 3. Confirmation of cocaine-regulated transcripts. A, RT-PCR
confirmation of a sample of four genes (RECK, PCDH8, CTGF, EPHB4) in
human hippocampus. Representative cases are shown. All genes were
normalized to an endogenous control gene cyclophilin. B, Graphical
representation of the relative mRNA levels (% of cyclophilin) in control
and cocaine groups (n=8, respectively). **p=0.01 (one-tailed t-test),
*p=0.05 (one-tailed t-test)
doi:10.1371/journal.pone.0001187.g003
Table 4. Comparison of relative expression data derived by
qPCR analysis.
......................................................................
Gene
a Fold-Change
b P-Value
RECK 1.98 0.015
SGKL 1.95 0.013
HCN2 1.79 0.031
LAMB1 1.73 0.007
OPHN1 1.61 0.035
PCDH8 1.44 0.001
EPHB4 21.43 0.033
ITGB6 1.35 0.021
CTGF 21.35 0.002
CTNNBIP1 21.32 0.047
aFor gene names, refer to Table 3
bNegative fold changes correspond to down-regulation of gene expression in
cocaine tissue relative to control tissue.
doi:10.1371/journal.pone.0001187.t004
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target of RECK in the human hippocampus of cocaine abusers.
Biological Pathway Analysis
The expression array data set allows the assessment of the
biological interaction of the protein products using Ariadne
Genomics PathwayAssist
TM biological pathway visualization and
analysis software. Figure 6 illustrates a schematic representation of
a potential signaling pathway involving RECK and MMP9
regulation of the cytomatrix in cocaine abusers compared to
control subjects. PathwayAssist analysis identified increased
expression of members of the protocadherin family and other
genes shown in the biological analysis network (BAN) which encode
proteins that are part of a signaling pathway for cell adhesion,
extracellular matrix remodeling and angiogenesis (ITGB6,
LAMB1, CTGF, EphB4). MMPs in the adult brain play a role in
remodeling of synaptic connections, a mechanism important for
synaptic plasticity, learning and memory. The results of this
analysis suggest a coordinated regulation of hippocampal RECK,
MMP9, protocadherins and other proteins of the cytomatrix that
have not been demonstrated previously in human postmortem
studies of gene expression in chronic cocaine abusers.
DISCUSSION
The present microarray study showed that 242 transcripts were
altered in the hippocampus from cocaine abusers compared to
control subjects. Increased gene expression in the hippocampus
predominated in the cocaine abusers, consistent with an acute
state of activation and recent ‘‘crack’’ cocaine use. In keeping with
this observation, transcriptional profiling in the human prefrontal
cortex provided evidence for two activational states, one that was
associated with recency of cocaine abuse [19]. While it is not
possible to assign a precise time course for cocaine-induced
transcriptional regulation from postmortem studies, surges or
peaks in transcriptional activity might occur during states of
cocaine craving or euphoria reported by cocaine abusers [20,21].
The limited number of genes upregulated in the hippocampus of
human cocaine abusers suggests that gene induction may be
a favored process for long-term neuronal adaptations. The
persistent effects of cocaine abuse on brain structure and function
likely underlie the inability of most cocaine addicts to remain
abstinent. In fact, part of the difficulty in preventing relapse is the
intense memory of the drug ‘‘high’’. Evidence from both animal
and human studies of cocaine addiction implicate memory-
associated brain regions and processes [21]. Transcriptional
responses to reinforcing effects of cocaine in the rat hippocampus
demonstrate a similar number albeit different gene profile in
cocaine conditioning [22]. The results shown here identify novel
gene targets for hippocampal synaptic plasticity in the human that
are dysregulated by cocaine exposure.
Matrix metalloproteinases (MMPs) are a large family of
extracellularly acting endopeptidases, the canonical substrates of
which are proteins of the extracellular matrix and adhesion
proteins [23]. In the brain, MMPs and their natural inhibitors
(TIMPs and RECK) are critical regulators of the structural and
functional remodeling of cellular architecture in the context of
pathophysiology [24]. However, functional and structural synaptic
remodeling through the MMP pathway is not limited to injury, but
is also a component of normal physiology, including the formation
of new networks that subserve learning and memory [25]. We
observed a significant cluster of gene transcripts associated with
synaptic structure and function, including cell-surface adhesion
proteins as well as proteins of the extracellular matrix with which
they interact. An unexpected finding was the upregulation of
RECK in the human hippocampus together with other receptors
and proteins which transduce cell-matrix interactions.
MMP9 may regulate synaptic plasticity by enabling structural
synaptic remodeling similar to that associated with activity-
dependent plasticity [26,27]. Recent studies in MMP9 knock-out
mice provide evidence that MMP9 is regulated with changes in
synaptic efficacy that enable late phase LTP and memory [28,29].
Figure 5. Regulation of MMP9 in human hippocampus with cocaine exposure. A, Representative Western immunoblots with antibodies against
human MMP2 and MMP9 demonstrate down-regulation of MMP9 protein expression in cocaine abusers compared to age-matched controls subjects
(n=8, respectively). The relative optical densities for active 92 kDa MMP9 and 72 kDa MMP2 illustrate quantitative fold change of MMP2 and MMP9
protein expression. Equal amount of total protein loading was confirmed by a-tubulin. B, Representative gel zymography. MMP9 activity in cocaine
abusers compared with age-matched drug-free control subjects demonstrate decreased activity. The graphs illustrate quantitative zymography of
MMP2 and MMP9. Levels of MMP2 activity were unchanged. Data are means6SEM. **p=0.01 (one-tailed t-test).
doi:10.1371/journal.pone.0001187.g005
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a signaling cascade that leads to anchoring of adhesion target
substrates with dendritic spine remodeling [30]. Previous work has
also implicated MMP9 in forms of protracted hippocampal
remodeling accompanying epileptogenesis [31]. In humans,
a kindling-like progression with cocaine abuse has been linked to
the occurrence of panic attacks [for review, 32]. Although none of
the cocaine cases used in this study had evidence of a terminal
seizure, kindling due to long-term cocaine abuse may lead to
adaptive and microstructural changes. At the level of gene
expression, the balance of these pathological and adaptive
processes probably determines whether a seizure will be manifest
or suppressed with chronic cocaine abuse [32].
The cadherin family of synaptic adhesion proteins is associated
with structural remodeling during late phase LTP [33]. Gene
expression profiling identified cell adhesion-related transcripts,
including upregulation of three members of the protocadherin
family and ITGB6 in the hippocampus of cocaine abusers.
Protocadherins are known targets for MMP-dependent cleavage
[34]. MMP9 binds also to synaptic integrins that anchor or
position them to cleave other target substrates to modulate
synaptic plasticity [35]. The effect of RECK as a modulator of the
extracellular milieu is a function of deregulated MMP activities
and perturbation of integrin signaling. Integrins are a large family
of heterodimeric transmembrane glycoproteins that attach cells to
extracellular matrix proteins of the basement membrane or to
ligands on other cells [36]. Integrins also modulate fast excitatory
transmission at hippocampal synapses [37]. Integrin activation
and signaling occurring over several minutes after LTP induction
are necessary for stabilizing synaptic potentiation, which may be
required for the conversion of new memories into a not readily
disrupted state [38]. Cleavage of the extracellular matrix molecule
laminin by the plasmin system has been suggested to be important
for CA1 LTP [39]. By inference, genes that encode or regulate cell
adhesion proteins in the human hippocampus make them likely
targets for processes that contribute to the reconsolidation of the
memory of the cocaine high.
RECK has been shown in studies of wound healing and cancer
metastasis to be a key regulator of the extracellular matrix integrity
and an inhibitor of angiogenesis [11,17]. In the embryonic brain,
RECK is specifically expressed in Nestin-positive neural precursor
cells [40]. However, the function of RECK in the adult brain in
mediating synaptic plasticity in the mature hippocampus is
unknown. Although RECK has been shown to negatively regulate
both MMP2 and MMP9, we observed a selective change in active
MMP9 protein expression in cocaine abusers. RECK inhibits
angiogenesis and a deficiency in RECK leads to excessive
degredation of the extracellular matrix [17,41]. Thus, the marked
increase in RECK message and protein levels suggests that there
may be a build up or enhanced maintenance of a remodeled
perivascular space in the hippocampus with chronic cocaine
abuse. Extracellular matrices consist mainly of collagen, proteo-
Figure 6. Schematic representation of coordinated gene expression changes and signaling pathways activated in the hippocampus of cocaine
abusers compared to age-matched and drug-free control subjects. The biological network was identified by incorporating the gene expression
results into Pathway Studio (Ariadne Genomics, Rockville, MD). Oval-shaped symbols represent regulated transcripts, square symbols illustrate cellular
or molecular functions and arrows denote some of their possible interactions. Upregulated transcripts are shown in red; purple illustrates
downregulated genes. Matrix metalloproteinases (hexagonal symbol, center) are zinc-dependent endopeptidases that degrade numerous
extracellular matrix proteins. MAP kinases and other essential kinases play roles in the expression of long-term potentiation. Many of the dysregulated
genes associated with cell adhesion and extracellular matrix remodeling are involved in memory and learning processes. Changes in MMP9 activity
are a requirement for remodeling of extracellular matrix cell adhesion molecules occurring with synaptic plasticity, which in turn is necessary for
memory consolidation. Abbreviations: HCN-2, hyperpolarization activated cyclic nucleotide-gated potassium channel 2; CTGF, Connective Tissue
Growth Factor; RECK, Reversion-inducing-cycteine-rich protein with kazal motifs; MMP9, matrix metalloproteinase 9; EphB4, ephrin receptor B4;
LAMB1, laminin beta 1; ITGB6, Integrin, beta 6.
doi:10.1371/journal.pone.0001187.g006
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RECK mediated inhibition of angiogenesis would result in fewer
vascular capillary sprouts from pre-existing blood vessels to allow
for the expansion and rearrangement of the perivascular space.
We observed a down regulation of CTGF and EphB4 receptor,
two gene transcripts that are regulators of postnatal angiogenesis
[42,43]. Since MMPs can degrade the entire extracellular matrix,
coordinated regulation of RECK, MMP9, CTGF and EphB4
suggests expansion of the extracellular matrix occurs with
morphological remodeling of the hippocampus in response to
chronic cocaine abuse.
The gene expression results demonstrate an upregulation of
HCN2 in cocaine abusers that may reflect the expansion and
remodeling of hippocampal circuits. Hyperpolarization-activated
cyclic nucleotide-gated ion channels (h-channels; HCN) modulate
the intrinsic excitability of pyramidal neurons [44,45]. The
hyperpolarization-activated cation channels of the HCN gene
family contribute to spontaneous rhythmic activity in both brain
and heart ([46,47]. Increasing evidence implicates h-channels in
activity dependent learning and memory [48,49]. Hippocampal
mossy fiber LTP is mediated by presynaptic h-channels [50]. MAP
kinases and other essential kinases play a role in late LTP [51].
HCN channels support pacemaking in various excitable cells [52–
54]. In the globus pallidus, HCN channels determine the rate and
regularity of autonomous pacemaking and sculpt the responses to
GABAergic input, allowing a persistent pacemaker reset to create
synchronous activity [55]. This mechanism may be relevant to
cocaine abuse in the context of extracellular matrix remodeling, in
that a cocaine induced reset of pacemaker activity might be an
underlying activity dependent metaplasticity that functions as
a trigger for the consolidation or adaptive generalization of
memories of an intense euphoria. Further studies are needed to
determine the functional relevance of upregulated HCN channels
as a neuroplastic response to cocaine in hippocampal synapses.
A recent single nucleotide polymorphism (SNP) whole genome
association study of drug abusers and matched control subjects
identifiedmanycelladhesiongenes[56].Theseincludedmembersof
the protocadherin family and genes whose products bind to cell
adhesion related protein complexes [61,62]. While these observa-
tionsdonotnegate othergenesthat confervulnerability to addiction,
they do agree with the observations shown here for hippocampal
gene expression in cocaine abusers. DRD2 has been shown to be
a vulnerability locus for addiction [57,58]. and PET imaging
demonstrates a decrease in DRD2 occupancy in drug addicted
subjects [59]. In agreement with these findings, gene expression
profiling of the human hippocampus demonstrated the expected
decrease in DRD2 expression in cocaine abusers compared to
control subjects. However, the results of whole genome SNP analysis
together with the gene expression profiling reported here provide
further support for a role of memory-associated brain regions in
cocaine addiction. Extracellular matrix remodeling in the human
hippocampus may be a persisting structural effect of chronic abuse
that consolidates the maladaptive memories of a drug-induced
euphoria. These cocaine induced changes in hippocampal structure
and function may be an underlying neural deficit that makes
abstinent cocaine addicts vulnerable to relapse despite the negative
consequences of continuing their cocaine habit.
METHODS
Subjects
Postmortem neuropathological specimens were obtained during
routine autopsy from cocaine-related deaths and age-matched
drug-free control subjects (Table 1). Medico-legal investigations of
the cause and manner of death were conducted by forensic
pathologists [12,13]. The circumstances of death and toxicology
data were reviewed carefully before classifying a cocaine in-
toxication case. Cocaine cases (N=10) were evaluated for
common drugs of abuse and alcohol and positive urine screens
were confirmed by quantitative analysis of blood. Blood cocaine
and benzoylecgonine were quantified using gas-liquid chromatog-
raphy with a nitrogen detector. Drug-free age-matched control
subjects (N=11) were selected from accidental or cardiac sudden
deaths with negative urine screens for all common drugs and there
was no history of licit or illicit drug use prior to death. All subjects
died suddenly without a prolonged agonal state. Since agonal state
may affect the RNA expression profile of postmortem brain tissue,
care was taken to match subject groups as closely as possible for
age, gender, PMI, and brain pH. Regional samples of postmortem
brain were taken from frozen coronal blocks based on surface and
cytoarchitectural landmarks. Hippocampal specimens were col-
lected with postmortem intervals less than 24 hours at autopsy
(Table 1). The hippocampus was sampled bilaterally for RNA and
protein from coronal slices taken at the anterior level of the
hippocampal body, including the dentate gyrus and the Cornu
Ammonis fields CA1- CA4 and the subiculum.
Microarray experiments
Total RNA isolation and biotin-labeled cRNA synthesis were
performed by Gene Logic Inc. (Gaithersburg, MD) using a TriZol
method and RNEasy columns, according to Affymetrix (Santa
Clara, CA) specificationsfrom50 mgofeach regionalsample. Mean
(SEM) values for postmortem RNA extraction were consistent with
excellent preservation of RNA quality, with a A260/A280 ratio of
2.1860.06 and RIN value of 7.6160.14 (Agilent Bioanalizer 2100
RNA Integrity Number, Technologies, Palo Alto, CA). We used the
Human Genome U133 AB set, containing around 45,000 probesets
representing .39,000 transcripts derived from around 33,000 well
substantiatedhumangenes(http://www.affymetrix.com).Genechip
analysis was performed with Microarray Analysis Suite version 5.0,
Data Mining Tool 2.0, and Microarray database software (available
at: http://www.affymetrix.com). The genes represented on the gene
chip were globally normalized and scaled to a signal intensity of 100.
Expression data was analyzed using Genesis 2.0 (GeneLogic Inc,
Gaithersburg, MD) and AVADIS (Strand Genomics, Redwood
City, CA).Several RNA integrity measureswereused inthisstudy to
detect samples with poor RNA quality before final analysis.
Microarray quality control parameters used included the following:
consistent b-actin and glyceraldehyde-3-phosphate dehydrogenase
59/39 (GAPDH) signal ratios, consistent number of genes detected as
present across arrays, noise (RawQ) and consistent scale factors to
select cases and controls for inclusion in the final microarray analysis
(Table 2). Problematic arrays were also detected using principal
components analysis (PCA). Nosignificant differences were observed
between the two groups in terms of age (p=0.10) or post-mortem
interval (p=0.13). Consistent with our previous reports, analysis of
postmorteminterval onRNA qualitycontrol parametersrevealed no
significant effects [60–62].
Data Analysis
Gene analysis was based on ‘present’ calls determined by
Microarray Analysis Suite 5.0 and genes were included if detected
in at least 75% of the subjects in each group to reduce the number
of false positives. Expression data were analyzed using Genesis
(GeneLogic, Inc., Gaithersburg, MD) and Avadis software (Strand
Genomics, Redwood City, CA). Gene expression values were
floored to 1 and then log2-transformed. Statistically differentiated
Cocaine Regulated Transcripts
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t-test to identify statistically significant fold changes p#0.05 and
a fold change/P-value combination of at least a 1.3 fold change
(FC) in either direction. The resulting P-values were adjusted for
multiple testing using the Benjamini-Hochberg procedure for
controlling the false discovery rate (Bioconductor Suite v. 2.12.0).
Cluster analysis was performed using an average-linkage hierar-
chical cluster group with a correlation metric. Expression patterns
in individual subjects and genes were clustered based on the initial
gene sets according to selected criteria.
Functional Cluster and Automated Pathway Analysis
The Affymetrix probeset identifiers were analyzed with gene
ontology (GO) terms and the results were visualized as
a hierarchical tree using GoSurfer (http://biosun1.Harvard.edu/
complab/gosurfer/). GoSurfer was used to identify GO categories
regulated by cocaine exposure by inclusion of lists of differentially
expressed genes. Functional ontological profiling of the expression
changes was performed using the Gene Score Resampling (GSR)
method (ErmineJ software v. 2.1.15, Columbia University, NY)
with distributions of scores (FC or P-values) determined across the
whole array [63]. The parameters used were the following:
maximum gene set size: 200; minimum gene set size: 5; with the
mean of replicates, 10,000 iterations and full resampling. The rank
and P-value computed by ErmineJ were used to calculate the most
overrepresented genes. Further functional profiling was then
performed using Pathway Studio (version 4.0 Ariadne Genomics,
Rockville, MD). The gene list that was generated by the
microarray data was imported into Pathway Studio to identify
and group genes into specific biopathways. This software uses
a proprietary database containing over 140,000 references on
protein interactions obtained from PubMed to generate a bi-
ological association network (BAN) of known protein interactions.
By overlaying microarray expression data onto the BAN, co-
regulated genes that define a specific signaling pathway were
identified to graphically illustrate all known relationships between
differentially expressed genes. The list of differentially expressed
genes was viewed also by visual inspection manually to confirm the
output of functional profiling tools.
Target validation and Protein Studies
Regional samples from all subjects included in the final microarray
analysis were used to validate positive findings for selected
transcripts by reverse transcription PCR (RT-PCR) and quanti-
tative real-time PCR and to confirm their relevance at the protein
level (Western blot and gel zymography). Subjects were selected
with researchers blinded to the microarray results.
RT-PCR reagents and cycling
RNA was extracted by TRIzol reagent (Invitrogen Life Technol-
ogies, Carlsbad, CA) followed by cDNA synthesis. For each
sample, 2 mg RNA was used for reverse transcription reaction with
SuperScript First-Strand Synthesis system (Invitrogen Life Tech-
nologies, Carlsbad, CA). cDNA synthesis was carried out in a total
volume of 20 ml. PCR was performed using PCR Master Mix
(Promega, Madison WI) in an Amplitron II (Thermolyne,
Dubuque, IA. USA). The PCR cycle consisted of denaturation
for 1 minute at 95uC, annealing for 1 minute at 56uC, and
extension for 2 minutes at 72uC followed by 5 minutes at 72uC.
Standard curves were constructed for each RT-PCR assay.
Cyclophilin was used as an internal standard. The primer pairs
used to assess expression levels were as follows: RECK (30 cycles):
59-CCTCAGTGAGCACAGTTCAGA-39, and 59-GCAGCA-
CACACACTGCTGTA-39, CTGF (28 cycles) 59-GAATGTAAA
GCTTGTCTGATCG-39 and 59-CATGTAACTTTTGGTCA-
CACTC-39, PCDH8 (26 cycles) 59-TCTGGCAGAGAAGCA-
GAGAAG-39 and 59-GTGCA GTACTTTCTCATAGAC-39,
EphB4 (32 cycles) 59-GTCTGACTTTGGCCTTTCCC-39 and
59-TGACATCACCTCCCACATCA-39,and cyclophilin (22 cycles)
59-TCCTAAAGCATA CGGG TCCTGGCAT-39,a n d5 9-CGC-
TCCATGGCC TCCACAATATTCA-39. The PCR productswere
visualized by 1.5% agarose gel electrophoresis. Images of gels were
evaluated for differences in band size and intensity.
Real-time PCR
Gene expression of selected target genes was measured in each
sample by real-time PCR using TaqMan Universal PCR Master
Mix and the Applied Biosystems 7900HT thermocycler (ABI,
Foster City, CA). TaqMan probes and proprietary primers were
designed based on previously reported sequences were purchased
from ABI (Foster City, CA).
The concentration of RNA was determined by spectrophotom-
etry, using Nanodrop-1000 (Nanodrop Technologies, Wilmington,
DE). Reverse transcription was performed with High-Capacity
cDNA Reverse Transcription kit using random primers from ABI
(FosterCity,CA).Geneexpressionlevelswerenormalizedtothoseof
the internal reference 18S rRNA. All samples were run in duplicate
reactions and no template control runs were performed for each
primer pair. cDNA was amplified using TaqMan Universal PCR
master mix reagent (ABI, Foster City, CA) at the following
conditions: 2 minutes at 50uC, 10 minutes at 95uC, 40 cycles:
15 seconds at 95uCa n d1m i n u t ea t6 0 uC. The target cDNA for
RECK, SGKL, LAMB1, PCDH8, ITGB6, HCN2, CTGF,
OPHN1, CTNNBIP1, EPHB4 was amplified using TaqMan ABI
MGB probe and primer set assay; Hs00221638_m1,
Hs00179430_m1, Hs00158620_m1, Hs00159910_m1,
Hs00168458_m1, Hs00606903_m1, Hs00170014_m1,
Hs00609994_m1, Hs00172016_m1, Hs00174752_m1 respectively
and normalized to 18S rRNA as a control (ABI MGB probe and
primer set assay ID Hs99999901_s1). Levels of 18S rRNA did not
differbetween thecontrol and cocaine groups.NormalizedCtvalues
(calculated automatically within the Applied Biosystems software
RQ manager 1.2.) were used to calculate expression ratios between
the cocaine and control groups. Expression ratios were subjected to
a log2 transform to produce fold change data. Student’s t-test was
used to test for significant differences between control and cocaine
groups. One-way analysis of variance (ANOVA) was used to
compare gene expression with a Tukey’s post-hoc comparison
(SPSS, Inc.).
Western Blot Analysis
Brain samples from hippocampus (100 mg tissue punch) were
homogenized with 35 strokes of a pestle in a glass homogenizer in
10 volumes of ice-cold homogenization buffer containing protease
inhibitors (50 mmol/L Tris.Cl, pH 7.4, 150 mmol/L NaCl, 1%
Nonidat P-40, 0.1% SDS and 0.1% deoxycholic acid with
16Protease Inhibitor Cocktail, Sigma, St. Louis, MO) and
centrifuged at 12,5006g for 30 min at 4uC. The supernatants
were collected and the total proteins were assayed using the
bicinchoninic acid assay kit (Pierce Chemical, Rockford, IL).
Protein extracts were processed on SDS-PAGE on 8% separating
and 4% stacking gel and transferred to Immobilon-P nitrocellulose
membrane (Millipore, Bedford, MA). The membranes were
blocked with 3% BSA in TBS for 1 hr at room temperature and
then incubated overnight at 4uC with the following primary
antibodies: anti-RECK (1:250, BD Transduction Laboratories,
Cocaine Regulated Transcripts
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Inc., South San Francisco, CA), anti-CTGF (1:5,000, Cell
Sciences, Norwood, MA), anti-MMP9 (1:5000, Chemicon In-
ternational, Temecula, CA) or anti-MMP2 (1:5000, Chemicon
International). Total protein loading was determined by western
blotting to anti-a-tubulin (1:10,000, Sigma). The membranes were
then incubated with horseradish peroxidase-conjugated anti-rabbit
or anti-mouse secondary antibody for 1 hour at room temperature
(1: 50,000, Pierce Chemical, Rockford, IL). Proteins in the blots
were visualized by SuperSignal West Pico Chemiluminescent
Substrate (Pierce Chemical). Exposures with maximal signal yet
below the photographic saturation point were quantitatively
analyzed by densitometry. Optical densities were determined
using ImageJ (version 1.36b, NIH Shareware) and expressed as
arbitrary units.
Zymography
Gelatinolytic MMP2 and MMP9 activities were measured in
postmortem brain tissue samples by the ultrasensitive gel zymo-
graphy technique [64]. Equal amounts of protein from each sample
homogenate were mixed with sample buffer (62.5 mM Tris?Cl, 2%
SDS,25%glycerol,0.01%bromophenolblue)and subjected to10%
gelatin Ready Zymogram Gel (Bio-Rad Laboratories, Hercules,
CA). Gels were washed twice for 30 min in 2% Triton X-100 and
incubated at 37uC for 20 hr in incubation buffer (50 mM Tris?Cl,
pH 7.5, 5 mM CaCl2,1mMZ n C l 2, 0.01% sodium azide). After
incubation,gelswerestainedin0.5%CoomassiebrilliantblueR-250
with 20% methanol and 10% acetic acid for 90 min. After staining,
gels were destained in 35% ethanol and 10% acetic acid for 60 min.
MMP2 and MMP9 activity was visible as clear bands on a blue
background. Standard protein markers (Bio-Rad Laboratories) and
human recombinant MMP2 and MMP9 proteins (Chemicon
International) were used to size and confirm the identity of the
gelatinolytic bands on the gels.
SUPPORTING INFORMATION
Table S1 Supplemental data table
Found at: doi:10.1371/journal.pone.0001187.s001 (0.14 MB
DOC)
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